The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome

    December 2022
    Mohamed Kandil
    Image of study
    TLDR Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.
    The commentary by Mohamed Kandil proposes a reclassification of Polycystic Ovary Syndrome (PCOS), a hormonal disorder common in women of reproductive age. Kandil suggests renaming it to "Polyfollicular Anovulatory Androgenic Syndrome" (PAAS) to better reflect its symptoms of multiple follicles in the ovaries, lack of ovulation, and high male hormone levels. He also proposes three other names for less severe forms of the syndrome: "Anovulatory Androgenic Syndrome", "Polyfollicular Androgenic Syndrome", and "Polyfollicular Anovulatory Syndrome". However, concerns are raised that the new name may not fully cover all complex metabolic abnormalities associated with the syndrome, such as obesity, acne, alopecia, hirsutism, and depression. The new naming system could enhance research efforts, but further consideration of the syndrome's full range of symptoms is needed.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 44 results

    Similar Research

    5 / 1000+ results